Visualitza per autor "Reni, Michele"
Ara mostrant els elements 1-5 d 5
-
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
Tempero, Margaret A.; Tabernero Caturla, Josep; Reni, Michele; Van Cutsem, Eric; Hendifar, Andrew E.; Macarulla Mercadé, Teresa; Oh, Do-Youn (Elsevier, 2021-05) -
Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy A Systematic Literature Review
Macarulla Mercadé, Teresa; Hendifar, Andrew E.; Reni, Michele; Riess, Hanno; Tempero, Margaret A.; Li, Chung-Pin (Wolters Kluwer Health, 2020-03) -
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Golan, Talia; Hammel, Pascal; Reni, Michele; Van Cutsem, Eric; Macarulla Mercadé, Teresa; Hall, Michael J (Massachusetts Medical Society, 2019-06-02) -
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
Goldstein, David; Von Hoff, Daniel D.; Reni, Michele; Tabernero Caturla, Josep; Ramanathan, Ramesh K.; Chiorean, E. Gabriela (Wolters Kluwer Health, 2020-07) -
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
taieb, julien; Seufferlein, Thomas; Reni, Michele; Palmer, Daniel H.; Cubillo, Antonio; Bridgewater, John; Macarulla, Teresa (BMC, 2023-09-18)